This is not FDA approval and can be revised or withdrawn
Assays, biomarkers, and phenotypic endpoints Biochemical and transcriptional readouts ERR target-gene panels spanning fatty-acid uptake/-oxidation (Cpt1b, Acadl/Acadm), OXPHOS (Ndufs, Uqcrc, Cox), TCA (Cs, Idh), and mitochondrial biogenesis (Ppargc1a, Tfam) provide proximal pharmacodynamic evidence of receptor engagement
Balibar, C
Further research is required to optimize the inducing dose and to discover models that can cover the full scope of AD pathogenesis
MEDICAL DISCLAIMER: This information is for educational purposes only and is not intended as medical advice
Jan 15, 2026 Most skincare marketing won't tell you: the reason standard approaches often fail isn't that you're doing something wrong